Retraction
Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model
Paper Information
Record ID:
50472
Author(s):
Asal Barshidi
Vahid Karpisheh
Fatemeh Karimian Noukabadi
Fariba Karoon Kiani
Mohammad Mohammadi
Negin Afsharimanesh
Farbod Ebrahimi
Seyed Hossein Kiaie
Jamshid Gholizadeh Navashenaq
Mohammad Hojjat‑Farsangi
Naime Majidi Zolbanin
Ata Mahmoodpoor
Hadi Hassannia
Sanam Nami
Pooya Jalali
Reza Jafari
Farhad Jadidi‑Niaragh
Vahid Karpisheh
Fatemeh Karimian Noukabadi
Fariba Karoon Kiani
Mohammad Mohammadi
Negin Afsharimanesh
Farbod Ebrahimi
Seyed Hossein Kiaie
Jamshid Gholizadeh Navashenaq
Mohammad Hojjat‑Farsangi
Naime Majidi Zolbanin
Ata Mahmoodpoor
Hadi Hassannia
Sanam Nami
Pooya Jalali
Reza Jafari
Farhad Jadidi‑Niaragh
Journal:
Publication Date:
June 17, 2022
Retraction Date:
December 26, 2023
(1.9 year years ago)
Subjects:
Institutions:
- Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
- Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
- Department of Biotechnology, Falavarjan Branch, Islamic Azad University, Isfahan, Iran
- Department of Cell and Molecular Biology, School of Advanced Sciences, Islamic Azad University, Tehran Medical Branch, Tehran, Iran
- Department of Microbiology, Faculty of Basic Sciences, Hamedan Branch, Islamic Azad University, Hamedan, Iran
- Nanoparticle Process Technology, Faculty of Engineering, University of Duisburg-Essen, Duisburg, Germany
- Department of Pharmaceutics, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
- Nano Drug Delivery Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
- Noncommunicable Diseases Research Center, Bam University of Medical Sciences, Bam, Iran
- Bioclinicum, Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden
- The Persian Gulf Marine Biotechnology Medicine Research Center, Bushehr University of Medical Sciences, Bushehr, Iran
- Experimental and Applied Pharmaceutical Sciences Research Center,, Urmia University of Medical Sciences, Urmia, Iran
- Department of Pharmacology and Toxicology, School of Pharmacy, , Urmia University of Medical Sciences, Urmia, Iran
- Department of Anesthesiology, School of Medicine, Imam Reza Medical Research & Training Hospital, Tabriz University of Medical Sciences, Tabriz, Iran
- Immunogenetic Research Center, Mazandaran University of Medical Sciences, Sari, Iran
- Cellular and Molecular Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia, Iran
- Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
- Research Center for Integrative Medicine in Aging, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran
Countries:
Article Type:
Publisher:
Springer
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1007/s11095-023-03647-1Additional Notes:
See also: https://pubpeer.com/publications/68029531E95310BD695B7035914648
Citations (10)
10
Total Citations3
Post-Retraction(30.0%)
7
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
0
After 2+ years
492
Days since retraction (latest)
Research advances in FGL1/LAG3 for cancer diagnosis and treatment: From basics to clinical practice
Keyao Hu, Gui-Ming Zhang, Haitao Niu et al. (4 authors)
Journal of Cancer Research and Therapeutics
Open Access
Published: May 2025
492 days after retraction
A novel anti-LAG-3/TIGIT bispecific antibody exhibits potent anti-tumor efficacy in mouse models as monotherapy or in combination with PD-1 antibody
Tongcheng Dai, Hao Sun, Tyler Liban et al. (10 authors)
Scientific Reports
Open Access
Published: May 2024
9 citations
9 citations
135 days after retraction
Dendritic cells as orchestrators of anticancer immunity and immunotherapy
Ignacio Heras‐Murillo, Irene Adán‐Barrientos, Miguel Á. Galán et al. (5 authors)
Nature Reviews Clinical Oncology
Published: Feb 2024
148 citations
148 citations
43 days after retraction
Nanotechnology Applications in Breast Cancer Immunotherapy
Ruijie Wang, Pramod Kumar, Moataz Reda et al. (7 authors)
Small
Published: Dec 2023
14 citations
14 citations
5 days before retraction
Nano-immunotherapy: overcoming delivery challenge of immune checkpoint therapy
Seyed Hossein Kiaie, Hossein Salehi‐Shadkami, Mohammad‐Javad Sanaei et al. (7 authors)
Journal of Nanobiotechnology
Open Access
Published: Sep 2023
40 citations
40 citations
96 days before retraction
Impaired function of dendritic cells within the tumor microenvironment
Zhihua Xiao, Ruiqi Wang, Xuyan Wang et al. (10 authors)
Frontiers in Immunology
Open Access
Published: Jun 2023
41 citations
41 citations
182 days before retraction
Immunotherapies against HER2-Positive Breast Cancer
Santiago Duro‐Sánchez, Macarena Román Alonso, Joaquı́n Arribas
Cancers
Open Access
Published: Feb 2023
13 citations
13 citations
321 days before retraction
MicroRNAs with Multiple Targets of Immune Checkpoints, as a Potential Sensitizer for Immune Checkpoint Inhibitors in Breast Cancer Treatment
Huiling Zhou, Wentao Jia, Lingeng Lu et al. (4 authors)
Cancers
Open Access
Published: Jan 2023
12 citations
12 citations
331 days before retraction
Recent Trends and Opportunities for the Targeted Immuno-Nanomaterials for Cancer Theranostics Applications
Clyde John, Kaahini Jain, Hema Brindha Masanam et al. (5 authors)
Micromachines
Open Access
Published: Dec 2022
6 citations
6 citations
377 days before retraction
Nano-drug delivery system for pancreatic cancer: A visualization and bibliometric analysis
Jiefeng Zhao, Fei-Long Zou, Jin-Feng Zhu et al. (7 authors)
Frontiers in Pharmacology
Open Access
Published: Oct 2022
16 citations
16 citations
434 days before retraction
Quick Stats
Total Citations:
10
Years Since Retraction:
1.9 year
Open Access:
Yes
Last Checked:
Jul 24, 2025